Research Recognised by EU

_________________________________________________________________

Iin Q4 2011 EU awarded a €6 million grant to an Enkam-led consortium to fund a clinical study in Alzheimer's disease of Enkam's novel lead development candidate, FGLs, which has demonstrated positive effects in neurodegeneration.in Alzheimer's disease ('NeuroFGL').

 

In Q1 2010 EU awarded a €2 million grant to an Enkam-led consortium to fund stemcell media development ('STEMCAM').

  • ENKAM Pharmaceuticals A/S
  • Fruebjergvej 3, Box 58
  • 2100 Copenhagen Ø
  • Denmark
  • Phone: +4539179715
  • Fax: +4539179714